PMDA drug package insert
当帰芍薬散料Aエキス細粒「分包」三和生薬
PMDA OTC drug · 湧永製薬（株） · package insert Jan 16, 2026
Key facts
| Brand names | 当帰芍薬散料Aエキス細粒「分包」三和生薬 |
|---|---|
| Companies | 製造販売元／三和生薬（株）,販売会社／湧永製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 当帰芍薬散 |
| Package insert date | Jan 16, 2026 |
| PMDA document key | 300303_J0901000151 |
| PMDA company code | 300303 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: